These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38098083)

  • 1. A dual-antigen malaria vaccine targeting Pb22 and Pbg37 was able to induce robust transmission-blocking activity.
    Gao W; Qiu Y; Zhu L; Yu X; Yang F; Chen M; He G; Liu Y; Cui L; Liu F; Zhu X; Cao Y
    Parasit Vectors; 2023 Dec; 16(1):455. PubMed ID: 38098083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria.
    Yang F; Liu F; Yu X; Zheng W; Wu Y; Qiu Y; Jin Y; Cui L; Cao Y
    Parasit Vectors; 2021 May; 14(1):241. PubMed ID: 33962671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential.
    Liu F; Li L; Zheng W; He Y; Wang Y; Zhu X; Tsuboi T; Cui L; Wang M; Cao Y
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved malaria parasite antigen Pb22 plays a critical role in male gametogenesis in Plasmodium berghei.
    Liu F; Yang F; Wang Y; Hong M; Zheng W; Min H; Li D; Jin Y; Tsuboi T; Cui L; Cao Y
    Cell Microbiol; 2021 Mar; 23(3):e13294. PubMed ID: 33222390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
    Kou X; Zheng W; Du F; Liu F; Wang M; Fan Q; Cui L; Luo E; Cao Y
    Parasit Vectors; 2016 Apr; 9():190. PubMed ID: 27038925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei.
    Bai J; Liu F; Yang F; Zhao Y; Jia X; Thongpoon S; Roobsoog W; Sattabongkot J; Zheng L; Cui Z; Zheng W; Cui L; Cao Y
    Vaccine; 2023 Jan; 41(2):555-563. PubMed ID: 36503858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
    Zheng W; Liu F; He Y; Liu Q; Humphreys GB; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Parasit Vectors; 2017 Jan; 10(1):8. PubMed ID: 28057055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.
    Zheng L; Pang W; Qi Z; Luo E; Cui L; Cao Y
    Parasit Vectors; 2016 Aug; 9(1):433. PubMed ID: 27502144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25.
    Wang PP; Jiang X; Bai J; Yang F; Yu X; Wu Y; Zheng W; Zhang Y; Cui L; Liu F; Zhu X; Cao Y
    Parasit Vectors; 2022 May; 15(1):175. PubMed ID: 35606790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nanoparticle vaccine displaying the ookinete PSOP25 antigen elicits transmission-blocking antibody response against Plasmodium berghei.
    Yao G; Min H; Yu X; Liu F; Cui L; Cao Y
    Parasit Vectors; 2023 Nov; 16(1):403. PubMed ID: 37932796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.
    Agrawal A; Bisharyan Y; Papoyan A; Bednenko J; Cardarelli J; Yao M; Clark T; Berkmen M; Ke N; Colussi P
    Protein Expr Purif; 2019 Jan; 153():7-17. PubMed ID: 30081196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multi-Stage
    McCaffery JN; Fonseca JA; Singh B; Cabrera-Mora M; Bohannon C; Jacob J; Arévalo-Herrera M; Moreno A
    Front Cell Infect Microbiol; 2019; 9():135. PubMed ID: 31119106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
    Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
    Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.
    Chowdhury DR; Angov E; Kariuki T; Kumar N
    PLoS One; 2009 Jul; 4(7):e6352. PubMed ID: 19623257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with various adjuvants, as a transmission blocking vaccine.
    Pourhashem Z; Nourani L; Sani JJ; Yousefi H; Pirahmadi S; Sabouri M; Raz A; Djadid ND; Zakeri S; Mehrizi AA
    Malar J; 2023 Dec; 22(1):374. PubMed ID: 38071314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous Expression and Evaluation of Novel
    de Jong RM; Singh SK; Teelen K; van de Vegte-Bolmer M; van Gemert GJ; Stone WJR; Locke E; Plieskatt J; Theisen M; Bousema T; Jore MM
    Front Immunol; 2022; 13():909060. PubMed ID: 35812379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.
    Wang J; Zheng W; Liu F; Wang Y; He Y; Zheng L; Fan Q; Luo E; Cao Y; Cui L
    Malar J; 2017 Nov; 16(1):458. PubMed ID: 29132428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
    Mizutani M; Iyori M; Blagborough AM; Fukumoto S; Funatsu T; Sinden RE; Yoshida S
    Infect Immun; 2014 Oct; 82(10):4348-57. PubMed ID: 25092912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-precipitation allows the efficient purification of a functional plant-derived malaria transmission-blocking vaccine candidate fusion protein.
    Beiss V; Spiegel H; Boes A; Kapelski S; Scheuermayer M; Edgue G; Sack M; Fendel R; Reimann A; Schillberg S; Pradel G; Fischer R
    Biotechnol Bioeng; 2015 Jul; 112(7):1297-305. PubMed ID: 25615702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies.
    Yusuf Y; Yoshii T; Iyori M; Mizukami H; Fukumoto S; Yamamoto DS; Emran TB; Amelia F; Islam A; Syafira I; Yoshida S
    Front Immunol; 2019; 10():2412. PubMed ID: 31681301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.